The increased global prevalence of obesity over the last 40‐years has driven a rise in
prevalence of obesity‐related co‐morbidities, including polycystic ovary syndrome (PCOS) …

Polycystic ovary syndrome (PCOS) is a common female condition typified by reproductive,
hyperandrogenic, and metabolic features. Polycystic ovary syndrome is a genetic condition …

Polycystic ovary syndrome (PCOS) has multiple etiologies including ovarian and adrenal
hyperandrogenism, neuro-endocrine and hypothalamic-pituitary dysfunction, and disorders …

Objective Development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and the American College of …

Background Polycystic ovary syndrome (PCOS) affects 8% to 13% of reproductive‐aged
women and is associated with reproductive and metabolic dysfunction. Obesity worsens the …

Purpose C-reactive protein (CRP) is a marker of chronic systemic inflammation frequently
used in cardiovascular disease risk assessment. The purpose of this meta-analysis was to …

Objective: Women with polycystic ovary syndrome (PCOS) often have cardiovascular
disease (CVD) risk factors. The Androgen Excess and Polycystic Ovary Syndrome (AE …

OBJECTIVE: To perform a review and metaanalysis of the studies evaluating the status of
serum inflammatory markers in women with polycystic ovary syndrome (PCOS). DESIGN …

The article provides an assessment and management of polycystic ovary syndrome (PCOS)
which has reportedly been shown to affect Australian reproductive-age women who are …

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder amongst women
of reproductive age and is associated with various metabolic perturbations, in addition to …